MRFF RCRDUN - Addressing the poor outcomes of young women with hormone receptor-positive, HER2-negative (HR+HER2-) early breast cancer

Redfern, Andrew (Investigator 01)
Loi, Sherene (Investigator 02)
Francis, Prudence (Investigator 03)
Fox, Stephen (Investigator 04)
Wilcken, Nicholas (Investigator 05)

Internal Medicine

Status	Active
Effective start/end date	1/01/22 → 31/12/26

Funding

Medical Research Future Fund MRFF